Article Versions Notes

Sharawi ZW, Alqurashi LA, Alharthi AM, Jali IM, Jamal MH, Bawazir Y, Mustafa M, Bahlas SM, Daghasi H, Alharthi TS, et al. Association of ABCG2 Polymorphisms with Methotrexate Efficacy and Toxicity in Saudi Rheumatoid Arthritis Patients. Pharmaceuticals. 2025; 18(9):1365. https://doi.org/10.3390/ph18091365

Sharawi, Zeina W., Lina A. Alqurashi, Ahlam M. Alharthi, Ibtisam M. Jali, Maha H. Jamal, Yasser Bawazir, Mohammad Mustafa, Sami M. Bahlas, Hassan Daghasi, Talal S. Alharthi, and et al. 2025. "Association of ABCG2 Polymorphisms with Methotrexate Efficacy and Toxicity in Saudi Rheumatoid Arthritis Patients" Pharmaceuticals 18, no. 9: 1365. https://doi.org/10.3390/ph18091365

Sharawi, Z. W., Alqurashi, L. A., Alharthi, A. M., Jali, I. M., Jamal, M. H., Bawazir, Y., Mustafa, M., Bahlas, S. M., Daghasi, H., Alharthi, T. S., Al Shaer, D. S., & Magadmi, R. (2025). Association of ABCG2 Polymorphisms with Methotrexate Efficacy and Toxicity in Saudi Rheumatoid Arthritis Patients. Pharmaceuticals, 18(9), 1365. https://doi.org/10.3390/ph18091365